microRNA-302c-3p inhibits renal cell carcinoma cell proliferation by targeting Grb2-associated binding 2 (Gab2)

Dong-Hua Gu1, Jia-Hui Mao2, Xiao-Dong Pan1,3

  • 1The Department of Urology, The Second Affiliated Hospital of Soochow University, Suzhou, China.

Oncotarget
|April 17, 2017
PubMed

Insights

Grb2-associated binding 2 (Gab2) is elevated in renal cell carcinoma (RCC), driving cell proliferation via Akt activation. MicroRNA-302c-3p (miR-302c-3p) inhibits this process by targeting Gab2.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Grb2-associated binding 2 (Gab2) is implicated in various cancers.
  • The role of Gab2 and its regulatory microRNAs in renal cell carcinoma (RCC) remains incompletely understood.
  • MicroRNA-302c-3p (miR-302c-3p) has been identified as a potential regulator of Gab2.

Purpose of the Study:

  • To investigate the expression and biological function of Gab2 in RCC.
  • To elucidate the relationship between Gab2, miR-302c-3p, and the Akt signaling pathway in RCC.
  • To determine the impact of the miR-302c-3p/Gab2 axis on RCC cell proliferation.

Main Methods:

  • Quantitative analysis of Gab2 expression in human RCC tissues and cell lines.
  • Manipulation of Gab2 and miR-302c-3p levels using knockdown (shRNA) and overexpression techniques.
  • Assessment of Akt activation status via Western blotting.
  • Cell proliferation assays (e.g., using 786-O RCC cells).

Main Results:

  • Gab2 expression is significantly upregulated in RCC tissues and cells, correlating with Akt over-activation and decreased miR-302c-3p levels.
  • Gab2 knockdown inhibits Akt activation and RCC cell proliferation, while Gab2 overexpression promotes these effects.
  • miR-302c-3p mimics decrease Gab2, inhibit Akt, and reduce proliferation; conversely, antagomiR-302c increases Gab2, activates Akt, and enhances proliferation.
  • The proliferative effect of miR-302c-3p depletion is dependent on Gab2 expression.

Conclusions:

  • miR-302c-3p functions as a tumor suppressor in RCC by targeting Gab2.
  • Gab2 upregulation, driven by miR-302c-3p downregulation, contributes to RCC pathogenesis through Akt hyper-activation and enhanced cell proliferation.
  • Targeting the miR-302c-3p/Gab2/Akt pathway may represent a therapeutic strategy for RCC.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...